Biocatalytic Synthesis of Chiral Pharmaceutical Intermediates

The production of single enantiomers of drug intermediates has become increasingly important in the pharmaceutical industry. Chiral intermediates and fine chemicals are in high demand from both the pharmaceutical and agrochemical industries for the preparation of bulk drug substances and agricultura...

Full description

Bibliographic Details
Main Author: Ramesh N. Patel
Format: Article
Language:English
Published: University of Zagreb Faculty of Food Technology and Biotechnology 2004-01-01
Series:Food Technology and Biotechnology
Subjects:
Online Access:http://hrcak.srce.hr/file/163397
_version_ 1797423407225110528
author Ramesh N. Patel
author_facet Ramesh N. Patel
author_sort Ramesh N. Patel
collection DOAJ
description The production of single enantiomers of drug intermediates has become increasingly important in the pharmaceutical industry. Chiral intermediates and fine chemicals are in high demand from both the pharmaceutical and agrochemical industries for the preparation of bulk drug substances and agricultural products. The enormous potential of microorganisms and enzymes for the transformation of synthetic chemicals with high chemo-, regio- and enantioselectivities has been demonstrated. In this article, biocatalytic processes are described for the synthesis of chiral pharmaceutical intermediates.
first_indexed 2024-03-09T07:47:41Z
format Article
id doaj.art-2b23eb6729d2464490e0c17b38daa030
institution Directory Open Access Journal
issn 1330-9862
1334-2606
language English
last_indexed 2024-03-09T07:47:41Z
publishDate 2004-01-01
publisher University of Zagreb Faculty of Food Technology and Biotechnology
record_format Article
series Food Technology and Biotechnology
spelling doaj.art-2b23eb6729d2464490e0c17b38daa0302023-12-03T02:42:20ZengUniversity of Zagreb Faculty of Food Technology and BiotechnologyFood Technology and Biotechnology1330-98621334-26062004-01-01424305325Biocatalytic Synthesis of Chiral Pharmaceutical IntermediatesRamesh N. Patel0Process R & D, Bristol-Myers Squibb, New Brunswick, NJ 08903, USAThe production of single enantiomers of drug intermediates has become increasingly important in the pharmaceutical industry. Chiral intermediates and fine chemicals are in high demand from both the pharmaceutical and agrochemical industries for the preparation of bulk drug substances and agricultural products. The enormous potential of microorganisms and enzymes for the transformation of synthetic chemicals with high chemo-, regio- and enantioselectivities has been demonstrated. In this article, biocatalytic processes are described for the synthesis of chiral pharmaceutical intermediates.http://hrcak.srce.hr/file/163397biocatalysischiral intermediatesanticancerantihypertensiveanti-infectiveenantioselective enzymatic de-protection
spellingShingle Ramesh N. Patel
Biocatalytic Synthesis of Chiral Pharmaceutical Intermediates
Food Technology and Biotechnology
biocatalysis
chiral intermediates
anticancer
antihypertensive
anti-infective
enantioselective enzymatic de-protection
title Biocatalytic Synthesis of Chiral Pharmaceutical Intermediates
title_full Biocatalytic Synthesis of Chiral Pharmaceutical Intermediates
title_fullStr Biocatalytic Synthesis of Chiral Pharmaceutical Intermediates
title_full_unstemmed Biocatalytic Synthesis of Chiral Pharmaceutical Intermediates
title_short Biocatalytic Synthesis of Chiral Pharmaceutical Intermediates
title_sort biocatalytic synthesis of chiral pharmaceutical intermediates
topic biocatalysis
chiral intermediates
anticancer
antihypertensive
anti-infective
enantioselective enzymatic de-protection
url http://hrcak.srce.hr/file/163397
work_keys_str_mv AT rameshnpatel biocatalyticsynthesisofchiralpharmaceuticalintermediates